# Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder

> **NCT02778360** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Mensia Technologies SA** · enrollment: 179 (estimated)

## Conditions studied

- Attention Deficit-Hyperactivity Disorder

## Interventions

- **DEVICE:** Neurofeedback NFT
- **DRUG:** Methylphenidate MPH

## Key facts

- **NCT ID:** NCT02778360
- **Lead sponsor:** Mensia Technologies SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 179 (ESTIMATED)
- **Last updated:** 2017-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02778360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02778360, "Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02778360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*